Reply to: "Comment on 'Oral diabetes medications other than dipeptidyl peptidase-4 inhibitors are not associated with bullous pemphigoid: A Finnish nationwide case-control study' and a case report of glucagon-like peptide-1 receptor agonist-induced bullous pemphigoid".
作者信息
Varpuluoma Outi, Tasanen Kaisa, Huilaja Laura
机构信息
PEDEGO Research Unit, University of Oulu, Oulu, Finland; Department of Dermatology, and Medical Research Center Oulu, Oulu University Hospital, Oulu, Finland.
PEDEGO Research Unit, University of Oulu, Oulu, Finland; Department of Dermatology, and Medical Research Center Oulu, Oulu University Hospital, Oulu, Finland.
出版信息
J Am Acad Dermatol. 2019 Jun;80(6):e191-e192. doi: 10.1016/j.jaad.2019.02.005. Epub 2019 Feb 7.
PMID:30738121
Abstract
摘要
Zotero 插件